[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635640":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":34,"collaborators":10,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":38,"sex":44,"minAge":45,"maxAge":10,"enrollmentInfo":46,"targetDuration":49,"studyType":50,"phases":10,"briefSummary":51,"conditions":52,"keywords":57,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Medical University of Warsaw","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Outpatient midline catheter",null,"Patients who receive a midline catheter for lidocaine infusion daily for ten days with two days weekend pause.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Piotr Mieszczański, MD","CONTACT","+48225021721","piotr.mieszczanski@wum.edu.pl",[19],{"facility":20,"status":21,"city":22,"state":10,"zip":10,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Szpital Kliniczny Dzieciątka Jezus","RECRUITING","Warsaw","Poland","PL",{"type":26,"coordinates":27},"Point",[28,29],21.01178,52.22977,{"lat":29,"lon":28},[32],{"name":14,"role":15,"phone":33,"phoneExt":10,"email":17},"+225021721",{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100635640","outpatient-midline-catheter-in-patients-receiveing-lidocaine-infusion-series-100635640",false,"NCT07555314","Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Series.","Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Therapy. A Prospective, Observational Study.","Midline Lid","Inclusion Criteria:\n\n* Patients qualified for lidocaine infusion therapy due to the chronic pain\n* Able to provide consent\n* ≥18 years of age\n\nExclusion Criteria:\n\n* Lack of patient consent","ALL","18 Years",{"count":47,"type":48},500,"ESTIMATED","10 Days","OBSERVATIONAL","This study will assess the efficacy, safety and practicality of using midline catheters for repeated intravenous lidocaine infusions in an outpatient pain management setting. Adult patients requiring serial lidocaine infusions for chronic pain will be enrolled and receive treatment through midline catheters over ten sessions.\n\nThe study will investigate if the midline catheters are a safe and effective option for delivering repeated lidocaine infusions in the outpatient setting, offering a balance between ease of placement, acceptable complication risk and good patients' comfort.",[53,54,55,56],"Midline Catheter","Lidocaine Infusion","Chronic Pain","Outpatient",[58,59,60,61],"midline catheter","lidocaine infusion","chronic pain","outpatient","2026-04-21",{"date":64,"type":65},"2026-04-29","ACTUAL",{"date":67,"type":48},"2026-04-20",{"date":69,"type":48},"2028-06-01",{"name":5,"class":6},1]